Author:
Löbenberg Raimar,Chacra Nadia B.,Stippler Erika S.,Shah Vinod P.,DeStefano Anthony J.,Hauck Walter W.,Williams Roger L.
Publisher
Springer Science and Business Media LLC
Reference19 articles.
1. World Health Organization. Essential medicines and pharmaceutical policies. 2010.
http://www.who.int/medicines/en/
. Accessed 14 Nov 2011.
2. Seear M, Gandhi D, Carr R, Dayal A, Raghavan D, Sharma N. J Clin Pharm Ther. 2011;36(4):488–95. doi:
10.1111/j.1365-2710.2010.01198.x
.
3. Caudron JM, Ford N, Henkens M, Macé C, Kiddle-Monroe R, Pinel J. Substandard medicines in resource-poor settings: a problem that can no longer be ignored. Trop Med Int Health. 2008;3(8):1062–72.
4. Van Roey J, Haxaire M. The need to reform current drug registration processes to improve access to essential medicines in developing countries. Pharm Med. 2008;22(4):207–13.
5. FDA. Orange book. 2010.
http://www.accessdata.fda.gov/scripts/cder/ob/default.cfm
. Accessed 14 Nov 2011.
Cited by
28 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献